中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 10
Oct.  2024
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2024  >  40(10): 1985-1991

Influence of metabolism-related factors on the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure and establishment of a predictive model

DOI: 10.12449/JCH241010

  • Department of Infectious Diseases，The Affiliated Hospital of Southwest Medical University，Luzhou，Sichuan 646000，China

More Information
  • Corresponding author: SHENG Yunjian， sheng200410@163.com （ORCID： 0000-0003-0772-5971）
  • Received Date: 2024-01-02
  • Accepted Date: 2024-02-22
  • Published Date: 2024-10-25
    Abstract
  •   Objective  To investigate the influence of metabolism-related factors （overweight and/or obesity， hyperglycemia， hypertension and dyslipidemia）on the 90-day prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure （HBV-ACLF）， and to establish a predictive model.  Methods  A retrospective analysis was performed for the clinical data of 365 patients with HBV-ACLF who were hospitalized in Department of Infectious Diseases， The Affiliated Hospital of Southwest Medical University， from June 2018 to June 2022， and according to the 90-day follow-up results， they were divided into survival group with 273 patients and death group with 92 patients. General information and related laboratory markers were collected from all patients. The t-test was used for comparison of normally distributed continuous data between groups， and the Mann-Whitney U test was used for comparison of non-normally distribution continuous data between groups； the chi-square test was used for comparison of categorical data between groups. A Logistic regression analysis was used to determine whether metabolism-related factors were independent risk factors for the 90-day prognosis of HBV-ACLF patients， and the Kaplan-Meier analysis was used to investigate the correlation between metabolism-related factors and the 90-day survival rate of HBV-ALCF patients. The area under the ROC curve （AUC） was used to compare the value of different scoring models in predicting the 90-day prognosis of HBV-ACLF patients.  Results  The multivariate Logistic regression analysis showed that hypertension （odds ratio ［OR］=4.698， 95% confidence interval ［CI］： 1.904‍ ‍—‍ ‍11.593， P=0.001）， alanine aminotransferase （OR=0.999， 95%CI： 0.999‍ ‍—‍ ‍1.000， P=0.010）， triglyceride （TG） （OR=4.979， 95%CI： 2.433‍ ‍—‍ ‍10.189， P<0.001）， high-density lipoprotein cholesterol （OR=0.258， 95%CI： 0.087‍ ‍—‍ ‍0.762， P=0.012）， apolipoprotein B （OR=0.118， 95%CI： 0.026‍ ‍—‍ ‍0.547， P=0.006）， and CLIF-C OF score （OR=2.275， 95%CI： 1.150‍ ‍—‍ ‍4.502， P<0.001） were independent influencing factors for the short-term prognosis of HBV-ACLF. The combined predictive model of metabolism-related factors had a larger AUC than the predictive model of a single factor， among which the predictive model of hypertension+TG+CLIF-C OF score had the largest AUC of 0.886. The patients with metabolism-related factors tended to have higher incidence rate of liver complications and 30- and 90-day mortality rates.  Conclusion  The presence of the metabolism-related factors such as hypertension and dyslipidemia can increase the severity of HBV-ACLF and the risk of short-term mortality， and the hypertension+TG+CLIF-C OF score predictive model has a good value in predicting the short-term prognosis of HBV-ACLF patients.

     

    • FullText(HTML)
  • loading
    • References(20)
  • [1]
    Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.

    中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
    [2]
    CHEN MJ, LI X, TANG SH. Advances in multi-dimensional assessment of liver function in the prognosis of patients with liver failure[J]. Clin J Med Offic, 2023, 51( 9): 901- 903, 907. DOI: 10.16680/j.1671-3826.2023.09.05.

    陈美娟, 李雪, 汤善宏. 多维度评估肝功能在肝衰竭患者预后中研究进展[J]. 临床军医杂志, 2023, 51( 9): 901- 903, 907. DOI: 10.16680/j.1671-3826.2023.09.05.
    [3]
    ASRANI S, SIMONETTO D, KAMATH P. Acute-on-chronic liver failure[J]. Clin Gastroenterol Hepatol, 2015, 13( 12): 2128- 39. DOI: 10.1016/j.cgh.2015.07.008.
    [4]
    MEZZANO G, JUANOLA A, CARDENAS A, et al. Global burden of disease: Acute-on-chronic liver failure, a systematic review and meta-analysis[J]. Gut, 2022, 71( 1): 148- 155. DOI: 10.1136/gutjnl-2020-322161.
    [5]
    BERZIGOTTI A, GARCIA-TSAO G, BOSCH J, et al. Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis[J]. Hepatology, 2011, 54( 2): 555- 561. DOI: 10.1002/hep.24418.
    [6]
    SARIN SK, CHOUDHURY A, SHARMA MK, et al. Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific Association for the Study of the Liver(APASL): An update[J]. Hepatol Int, 2019, 13( 4): 353- 390. DOI: 10.1007/s12072-019-09946-3.
    [7]
    Chinese Society of Hepatology and Chinese Society of Infectious Disease, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B: 2019 version[J]. J Clin Hepatol, 2019, 35( 12): 2648- 2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.

    中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35( 12): 2648- 2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.
    [8]
    Metabolic Syndrome Research Collaboration Group, Diabetes Branch, Chinese Medical Association. Recommendations on metabolic syndrome, diabetes branch, Chinese Medical Association[J]. Chin J Diabetes, 2004, 12( 3): 5- 10.

    中华医学会糖尿病学分会代谢综合征研究协作组. 中华医学会糖尿病学分会关于代谢综合征的建议[J]. 中华糖尿病杂志, 2004, 12( 3): 5- 10.
    [9]
    FAN Q, LI Z. Liver transplantation for acute-on-chronic liver failure[J]. Organ Transplantation, 2022, 13( 3): 333- 337. DOI: 10.3969/j.issn.1674-7445.2022.03.008.

    范祺, 李照. 慢加急性肝衰竭的肝移植治疗[J]. 器官移植, 2022, 13( 3): 333- 337. DOI: 10.3969/j.issn.1674-7445.2022.03.008.
    [10]
    FAHED G, AOUN L, ZERDAN M BOU, et al. Metabolic syndrome: Updates on pathophysiology and management in 2021[J]. Int J Mol Sci, 2022, 23( 2): 786. DOI: 10.3390/ijms23020786.
    [11]
    LAM DW, LEROITH D, FEINGOLD KR, et al. Metabolic syndrome[R]. Endotext. MDText.com, Inc, 2000.
    [12]
    HIRODE G, WONG RJ. Trends in the prevalence of metabolic syndrome in the United States, 2011-2016[J]. JAMA, 2020, 323( 24): 2526- 2528. DOI: 10.1001/jama.2020.4501.
    [13]
    SETO WK. Chronic hepatitis B and metabolic risk factors: A call for rigorous longitudinal studies[J]. World J Gastroenterol, 2019, 25( 3): 282- 286. DOI: 10.3748/wjg.v25.i3.282.
    [14]
    REN HN, WANG JN, GAO Y, et al. Metabolic syndrome and liver-related events: A systematic review and meta-analysis[J]. BMC Endocr Disord, 2019, 19( 1): 40. DOI: 10.1186/s12902-019-0366-3.
    [15]
    DIAO YT, HU DQ, HU X, et al. The role of metabolic factors and steatosis in treatment-Naïve patients with chronic hepatitis B and normal alanine aminotransferase[J]. Infect Dis Ther, 2022, 11( 3): 1133- 1148. DOI: 10.1007/s40121-022-00629-5.
    [16]
    DUSEJA A, DE A, TANEJA S, et al. Impact of metabolic risk factors on the severity and outcome of patients with alcohol-associated acute-on-chronic liver failure[J]. Liver Int, 2021, 41( 1): 150- 157. DOI: 10.1111/liv.14671.
    [17]
    ENGIN A. The pathogenesis of obesity-associated adipose tissue inflammation[J]. Adv Exp Med Biol, 2017, 960: 221- 245. DOI: 10.1007/978-3-319-48382-5_9.
    [18]
    PARADIS V, PERLEMUTER G, BONVOUST F, et al. High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis[J]. Hepatology, 2001, 34( 4 Pt 1): 738- 744. DOI: 10.1053/jhep.2001.28055.
    [19]
    PERGOLA GD, PANNACCIULLI N. Coagulation and fibrinolysis abnormalities in obesity[J]. J Endocrinol Invest, 2002, 25( 10): 899- 904. DOI: 10.1007/BF03344054.
    [20]
    LAAT-KREMERS RD, CASTELNUOVO AD, van der VORM L, et al. Increased BMI and blood lipids are associated with a hypercoagulable state in the moli-sani cohort[J]. Front Cardiovasc Med, 2022, 9: 897733. DOI: 10.3389/fcvm.2022.897733.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(5)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (141) PDF downloads(25) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return